Acesso livre
Acesso livre

Destaques

Opinião | Razões para os preprints serem bons para os pacientes.

13 Mai, 2022 | 12:58h

Why preprints are good for patients – Nature Medicine

 

Comentário no Twitter

 


Revisão sistemática | Antibioticoprofilaxia na prevenção de endocardite bacteriana após procedimentos dentários.

13 Mai, 2022 | 12:56h

Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures – Cochrane Library

Resumo: Antibiotics for the prevention of bacterial endocarditis (severe infection or inflammation of the lining of the heart chambers) in dentistry – Cochrane Library

 

Comentário no Twitter

 


Estudo randomizado | Avaliação da vacina de mRNA-1273 contra Covid-19 em crianças de 6 a 11 anos de idade.

13 Mai, 2022 | 12:55h

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age – New England Journal of Medicine

 

Comentário no Twitter

 


Inibição de capsídio com lenacapavir na infecção pelo HIV-1 multirresistente.

13 Mai, 2022 | 12:53h

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário: Lenacapavir for HIV Infection in a Multidrug-Resistant Study Cohort – ContagionLive


Estudo de coorte | Impacto da adoção de estilo de vida saudável sobre o ganho de tempo de vida a partir da meia-idade.

13 Mai, 2022 | 12:52h

Impact of modifiable healthy lifestyle adoption on lifetime gain from middle to older age – Age and Ageing

 

Comentário no Twitter

 


Atualização epidemiológica | Hepatite de origem desconhecida em crianças.

13 Mai, 2022 | 12:50h

Epidemiological update: Hepatitis of unknown aetiology in children – European Centre for Disease Prevention and Control

Conteúdos relacionados:

Unexplained hepatitis cases in kids rise to 348 in 20 nations – CIDRAP

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing 2 – UK Health Security Agency

With usual suspects ruled out, disease detectives try to crack mystery of viral hepatitis cases in kids – STAT

Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022 – Morbidity and Mortality Weekly Report

The CDC and WHO Have Reported an Unusual Cluster of Severe Pediatric Hepatitis Cases – Science-Based Medicine

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press

 

Comentário no Twitter (fio – clique para saber mais)

 


USPSTF mantém recomendação contra o rastreamento de doença pulmonar obstrutiva crônica (DPOC) em adultos assintomáticos.

12 Mai, 2022 | 15:26h

Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement – JAMA

Editorial: Screening for Chronic Obstructive Pulmonary Disease: Challenges and Opportunities – JAMA

Relatório de evidência: Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Página do paciente: Screening for Chronic Obstructive Pulmonary Disease – JAMA

Entrevista com a autora: USPSTF Recommendation: Screening for Chronic Obstructive Pulmonary Disease – JAMA

Comentário: USPSTF Continues to Recommend Against COPD Screening in Asymptomatic Adults – AJMC

 

Comentário no Twitter

 


Uso de novas estratégias de desenvolvimento de diretrizes para tratamento de osteomielite piogênica em adultos: diretriz de consenso do grupo WikiGuidelines.

12 Mai, 2022 | 15:23h

Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement – JAMA Network Open

Comentário: A new approach to medical guidelines, taking inspiration from Wikipedia – University of Michigan

 

Comentário no Twitter

 


AHA: chamado para ação na doença cardiovascular em mulheres: epidemiologia, alertas, acesso e disponibilidade de cuidado de saúde equitativo.

12 Mai, 2022 | 15:21h

Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association – Circulation

Comunicado de imprensa: Investment, action urged to improve access, quality and equity in women’s heart health – American Heart Association


Estudo sugere que adaptar o rastreamento do diabetes por raça e etnia pode levar a diagnóstico precoce.

12 Mai, 2022 | 15:20h

Comentário: Tailoring diabetes screening by race, ethnicity may lead to earlier diagnosis – ACP Internist

Comunicado de imprensa: Screening Some Sooner May Reduce Racial and Ethnic Disparities in Diabetes Diagnosis, Researchers Show – Beth Israel Deaconess Medical Center

Estudo original: Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

 

Comentário do autor no Twitter (fio – clique para saber mais)

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.